Combination of anti-CD20 and hetrombopag in relapsed/refractory immune thrombocytopenia: a case series
Combining anti-CD20 monoclonal antibody with hetrombopag may offer therapeutic benefits in patients with relapsed/refractory ITP.
Authors
- Yan Wang (ORCID: https://orcid.org/0009-0000-0159-972X)
- Xiaolei Zhang (ORCID: https://orcid.org/0000-0003-3701-2032)
- Li Yang (ORCID: https://orcid.org/0000-0002-4710-059X)
- Lina Xing (ORCID: https://orcid.org/0000-0001-7746-5445)
- Yujie Guo (ORCID: https://orcid.org/0000-0003-1174-7532)
- Feng-Ru Lin
- Xuquan Zhou
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fmed.2025.1701819
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00